Taking aim against prostate cancer disparities in African American men
As both a clinician and scientist Kosj Yamoah, MD, PhD, has dedicated his career to increasing access and quality of care for prostate cancer patients, particularly African American men.\n\nIn this conversation Dr. Yamoah describes the challenges associated with knowing when prostate cancer is likely to be aggressive. And he talks about the increased incidence and mortality among African American prostate cancer patients, touching on causal factors as well as issues around incidence, diagnosis, treatment delivery, treatment response, and outcomes. \n\nKosj Yamoah, MD, PhD, is a radiation oncologist and Assistant Professor of Radiation Oncology at Moffitt Cancer Center & Research Institute.\n\n1:08 \u2013 The biggest challenge clinicians face when treating prostate cancer patients\n\n3:01 \u2013 Some of the issues faced by African American prostate cancer patients\n\n5:14 \u2013Disparities and health inequity issues for African American prostate cancer patients \n\n8:25 \u2013 On his research into biomarkers for prostate cancer\n\n12:30 \u2013 On prospectively validating the effectiveness of Decipher\u2014a genomic test looking at gene expression within tumor tissue to measure its aggressiveness\u2014in African American men\n\n17:06 \u2013 His work in West Africa, where \u201cprostate cancer is the 2nd leading cause of cancer death,\u201d as part of the Men of African Descent and Carcinoma of the Prostate (MADCaP) consortium\n\n21:17 \u2013 On starting high school at age 7 (!!!)\n\n26:25 \u2013 A heartfelt message for cancer survivors and caregivers